Dashboard
Manage Tickers

OPTOpthea Ltd

Nasdaq opthea.com


$ 3.52 $ -0.09 (-2.49 %)    

Wednesday, 15-May-2024 14:29:20 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.51 $ 3.59 (0.8 %)
DIA $ 398.38 $ 0.49 (0.12 %)
SPY $ 528.82 $ 2.86 (0.55 %)
TLT $ 92.06 $ 0.22 (0.24 %)
GLD $ 220.82 $ 1.58 (0.72 %)
$ 3.61
$ 3.61
$ 0.00 x 0
$ 0.00 x 0
$ 3.52 - $ 3.61
$ 1.60 - $ 4.40
35,732
na
1.73B
$ 0.57
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Watching Protara Therapeutics, Opthea Ltd....
05/09/2024 14:24:33

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-surge-over-400-says-oppenheimer/

opthea-reports-1571m-in-cash-and-cash-equivalents-as-of-december-31-2023-provides-business-updates
Opthea Reports $157.1M In Cash And Cash Eq...
02/28/2024 22:58:59

opthea-has-completed-enrollment-in-coast-phase-3-trial-of-sozinibercept-plus-aflibercept-for-wet-age-related-macular-degeneration-enrollment-in-shore-study-is-expected-to-be-completed-in-q2-2024-topline-data-from-both-trials-are-expected-by-mid-2025
Opthea Has Completed Enrollment In COAST P...
02/14/2024 11:17:17

why-netflix-shares-are-trading-higher-by-10-here-are-20-stocks-moving-premarket
Why Netflix Shares Are Trading Higher By 1...
01/24/2024 13:14:23

Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-e...

why-is-retinal-diseases-focused-opthea-stock-trading-higher-today
Why Is Retinal Diseases-Focused Opthea Sto...
12/27/2023 15:03:56

Opthea Limited (NASDAQ: OPT) on Wednesday said it expects to receive the remaining $35 million committed funds under the Develo...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
12/27/2023 13:07:19

opthea-expects-to-receive-the-remaining-35m-committed-funds-under-development-funding-agreement-with-carlyle-and-abingworth
Opthea Expects To Receive The Remaining $3...
12/27/2023 11:02:05

This financing is non-dilutive to shareholders, with no equity issued to Carlyle, Abingworth or the new co-investor

opthea-has-received-an-a88m-59m-rd-tax-credit-from-the-australian-taxation-office
Opthea Has Received An A$8.8M ($5.9M) R&D ...
12/19/2023 11:02:52

opthea-limited-appoints-frederic-guerard-as-chief-executive-officer-effective-immediately-guerard-to-replace-megan-baldwin-who-will-transition-to-founder-and-chief-innovation-officer-post-company-also-appoints-peter-lang-as-chief-financial-officer
Opthea Limited Appoints Frederic Guerard A...
10/27/2023 09:39:00

stocks-that-hit-52-week-lows-on-thursday
Stocks That Hit 52-Week Lows On Thursday
09/21/2023 16:08:37

  During the session on Thursday, 461 stocks hit new 52-week lows.

oppenheimer-maintains-outperform-on-opthea-lowers-price-target-to-16
Oppenheimer Maintains Outperform on Opthea...
09/13/2023 16:25:04

Oppenheimer analyst Hartaj Singh maintains Opthea (NASDAQ:OPT) with a Outperform and lowers the price target from $31 to $16.

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
09/08/2023 17:58:01

  Friday's session saw 225 companies set new 52-week lows.

why-novocure-are-trading-lower-by-around-31-here-are-other-stocks-moving-in-mondays-mid-day-session
Why NovoCure Are Trading Lower By Around 3...
08/28/2023 17:52:48

Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
08/28/2023 17:31:11

opthea-successfully-completes-institutional-offer-and-increases-capital-raising-to-a900m-576m
Opthea Successfully Completes Institutiona...
08/28/2023 09:34:35

Opthea Limited (Opthea or the Company) ((ASX:OPT, NASDAQ:OPT) is pleased to announce the successful completion of the instituti...

hc-wainwright--co-reiterates-buy-on-opthea-maintains-14-price-target
HC Wainwright & Co. Reiterates Buy on Opth...
08/01/2023 10:14:03

HC Wainwright & Co. analyst Matthew Caufield reiterates Opthea (NASDAQ:OPT) with a Buy and maintains $14 price target.

american-medical-associations-united-states-adopted-names-council-has-approved-and-adopted-the-nonproprietary-drug-name-sozinibercept-for-optheas-lead-biologic-drug-candidate-opt-302
American Medical Association's United Stat...
07/26/2023 10:06:33

ef-hutton-reiterates-buy-on-opthea-maintains-23-price-target
EF Hutton Reiterates Buy on Opthea, Mainta...
05/16/2023 11:13:21

EF Hutton analyst Elemer Piros reiterates Opthea (NASDAQ:OPT) with a Buy and maintains $23 price target.

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
04/17/2023 15:00:43

ef-hutton-initiates-coverage-on-opthea-with-buy-rating-announces-price-target-of-23
EF Hutton Initiates Coverage On Opthea wit...
04/17/2023 12:42:02

EF Hutton analyst Elemer Piros initiates coverage on Opthea (NASDAQ:OPT) with a Buy rating and announces Price Target of $23.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION